BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 6420922)

  • 1. Investigations of the lupus-like inhibitor by-passing activity of platelets.
    Howard MA; Firkin BG
    Thromb Haemost; 1983 Dec; 50(4):775-9. PubMed ID: 6420922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Similar mechanism of various lupus anticoagulants.
    Exner T
    Thromb Haemost; 1985 Feb; 53(1):15-8. PubMed ID: 3922078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sensitivity of different coagulation reagents to the presence of lupus anticoagulants.
    Brandt JT; Triplett DA; Musgrave K; Orr C
    Arch Pathol Lab Med; 1987 Feb; 111(2):120-4. PubMed ID: 3101649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of procoagulant phospholipid interfering in tests for lupus anticoagulant.
    Exner T; Low J
    Thromb Res; 2004; 114(5-6):547-52. PubMed ID: 15507290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A lupus anticoagulant neutralization procedure using the patient's own platelets.
    Carroll P; Ray M; Just S; Hawson G
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):523-7. PubMed ID: 7841308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that von Willebrand factor is not required for the clotting of plasma in the presence of platelets and kaolin (Hardisty-Hutton test).
    McPherson J; Soberano ME; Macdonald C; Zucker MB
    Thromb Haemost; 1984 Apr; 51(2):272-4. PubMed ID: 6429885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common variable immune deficiency syndrome associated with lupus anticoagulant.
    Ruggieri AP; Galbraith RM; Lazarchick J
    Clin Exp Rheumatol; 1985; 3(1):71-3. PubMed ID: 3919983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor XIII in human plasma and platelets.
    McDonagh J; McDonagh RP; Delâge JM; Wagner RH
    J Clin Invest; 1969 May; 48(5):940-6. PubMed ID: 5780202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The laboratory diagnosis of lupus anticoagulants.
    Lazarchick J; Kizer J
    Arch Pathol Lab Med; 1989 Feb; 113(2):177-80. PubMed ID: 2492798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction of clotting factor "deficiencies" in plasma from patients with lupus-like anticoagulants.
    Clyne LP; Honig CL; Dainiak N
    Thromb Haemost; 1984 Jul; 51(3):317-20. PubMed ID: 6437003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of two simple tests for the lupus anticoagulant.
    Exner T
    Am J Clin Pathol; 1985 Feb; 83(2):215-8. PubMed ID: 3918436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A circulating lupus-like coagulation inhibitor induced by chlorpromazine.
    Tollefson G; Rodysill K; Cusulos M
    J Clin Psychopharmacol; 1984 Feb; 4(1):49-51. PubMed ID: 6420448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The laboratory heterogeneity of lupus anticoagulants.
    Triplett DA; Brandt JT; Maas RL
    Arch Pathol Lab Med; 1985 Oct; 109(10):946-51. PubMed ID: 3929747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dilute phospholipid APTT: a sensitive assay for verification of lupus anticoagulants.
    Alving BM; Baldwin PE; Richards RL; Jackson BJ
    Thromb Haemost; 1985 Oct; 54(3):709-12. PubMed ID: 3937268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The lupus inhibitor: a study of its heterogeneity.
    Coots MC; Miller MA; Glueck HI
    Thromb Haemost; 1981 Dec; 46(4):734-9. PubMed ID: 7330826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysfibrinogenemia and lupus anticoagulant in a patient with recurrent thrombosis.
    Al-Mondhiry H; Galanakis D
    J Lab Clin Med; 1987 Dec; 110(6):726-33. PubMed ID: 3119749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma requirement for expression of lupus-like anticoagulant.
    Clyne LP
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(6):841-4. PubMed ID: 2436999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological and clinical heterogeneity of lupus and lupus-like anticoagulant in fifty-seven patients.
    Horellou MH; Aurousseau MH; Boffa MC; Conrad J; Wiesel ML; Samama M
    J Med; 1987; 18(3-4):199-217. PubMed ID: 3480933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Idiopathic thrombocytopenic purpura complicated with circulating lupus anticoagulant].
    Saito K; Ishiyama T; Hashimoto M; Osawa H; Koike M; Sugimoto M; Horie S; Wakabayashi Y; Hirose S
    Rinsho Ketsueki; 1990 Jan; 31(1):52-6. PubMed ID: 2107346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The lupus inhibitor].
    Carreras LO; Vermylen J
    Sangre (Barc); 1981; 26(5-A):610-8. PubMed ID: 6798699
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.